ORKA vs PRAX Stock Comparison

ORKA currently leads PRAX in this stock comparison, with AIQ scores of 77 vs 57. The clearest difference is momentum.

Market data as of Nov 15, 2026 market close· AIQ score gap 20 points
ORKA
Healthcare
vs
PRAX
Healthcare
ORKA
Oruka Therapeutics, Inc.
Leads
Price
$105
Day move
+0.34%
AIQ Score
77/100
Best edge
Momentum
Sector
Healthcare
PRAX
Praxis Precision Medicines, Inc.
Price
$328
Day move
+1.04%
AIQ Score
57/100
Best edge
Balanced
Sector
Healthcare

What is the main difference between ORKA and PRAX?

ORKA leads the current stock comparison as Oruka Therapeutics, Inc., with the clearest separation coming from momentum and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Oruka Therapeutics, Inc. vs Praxis Precision Medicines, Inc.

Data as of Nov 15, 2026· market close· Healthcare· Coverage 62/66 fields· High confidence
AIQ VerdictStableAIQ Comparison Conviction 9/10

ORKA leads

ORKA leads by 20 AIQ points, primarily on Momentum and Quality, and the lead has widened from 11 points over 30 sessions. Wall Street currently favors PRAX on target upside.

Stable: 4 of 5 evidence groups support ORKA, its lead is widening, and its current signal state is conflicted.

Evidence agreement: 4 of 5Comparison trend: Strengthening
ORKA

Oruka Therapeutics, Inc.

Leads
AIQ Score
77/100
AIQ Edge Score
10/10
PRAX

Praxis Precision Medicines, Inc.

AIQ Score
57/100
AIQ Edge Score
9/10

The Algovestiq AIQ Score currently favors ORKA over PRAX, 77 versus 57 as of Nov 15, 2026. ORKA's advantage is driven primarily by stronger momentum and quality. ORKA also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors PRAX. 4 of 5 covered evidence groups favor ORKA today, and the comparison is rated Stable on stability: the leader is throwing conflicting signals. ORKA lead: Strengthening — the AIQ differential moved from 11 to 20 points over 30 sessions.

Compare Oruka Therapeutics, Inc. and Praxis Precision Medicines, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

ORKA
+313.1%
PRAX
+492.5%

Total return comparison

Growth of $10,000, distributions reinvested

ORKA $41,314 · PRAX $59,251

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare ORKA and PRAX against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

ORKA advantage
0
PRAX advantage
  • Momentum81 vs 48
    ORKA +33
  • Quality83 vs 72
    ORKA +11
  • Risk Resilience53 vs 47
    ORKA +6

4 of 5 evidence groups favor ORKA. ORKA’s edge is concentrated in momentum and quality.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

ORKA+1 AIQ

Largest factor move: Momentum +2

New signals

  • Low Volume Rally Warning — bearish, volume, short horizon (0.68x)
PRAX+1 AIQ

Largest factor move: Momentum +1

New signals

  • Low Volume Rally Warning — bearish, volume, short horizon (0.72x)

ORKA's lead was unchanged in the latest session.

Deeper signal detail for each name lives on its own signals page — ORKA and PRAX both carry a full feed there.

The central trade-off

ORKA (Oruka Therapeutics, Inc.): the stronger current systematic profile, led by momentum and quality.

PRAX (Praxis Precision Medicines, Inc.): the counter-case, on analyst expectations — but at materially higher volatility, 93.7% against 64.3%.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

ORKA

ORKA on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

ORKA

ORKA on combined revenue and EPS growth.

Value

Even

The two are level on Value.

Momentum

ORKA

ORKA on the Momentum factor, by 33 points.

Lower downside

ORKA

ORKA on Risk Resilience, by 6 points.

Analyst upside

PRAX

PRAX on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors ORKA, analyst targets favor PRAX. That disagreement is the most useful thing on this page.

MeasureORKAPRAXNote
Implied upside to target+9.2%+101.2%PRAX has more room
Target dispersion+13%+19.8%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering1321Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

4 of 5 covered evidence groups favor ORKA. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreORKA77 vs 57
FundamentalsORKArevenue growth 0% vs 0%; EPS growth 4.5% vs -12.5%; TTM ROE -4.2% vs -7.5%; gross margin 0% vs 0%; operating margin 0% vs 0%
ValuationNot coveredNot covered
TechnicalsORKAPrice vs 50-day 17.5% vs 13.2%; vs 200-day 45% vs 4.3%
Risk ResilienceORKARisk Resilience 53 vs 47
Analyst expectationsPRAXTarget upside 9.2% vs 101.2%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of ORKA and PRAX and are excluded from the count.

AIQ Decision Stability

Stable

The conclusion rests on a wide gap and broad agreement. It is unlikely to turn on a single session.

  • The AIQ gap is wide at 20 points. (supports the conclusion holding)
  • 4 of 5 covered evidence groups point the same way. (supports the conclusion holding)
  • The leader's advantage has been widening. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on ORKA.

How the comparison changed

45 daily snapshots · Sep 14 – Nov 13

ORKA lead: Strengthening — the AIQ differential moved from 11 to 20 points over 30 sessions.

Sep 14ORKA leads above the line · PRAX leads belowNov 13
Today
ORKA +20
77 vs 57
7 sessions ago
ORKA +18
76 vs 58
30 sessions ago
ORKA +11
68 vs 57
90 sessions ago
Not covered

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

ORKAConflicted

4 bullish / 1 bearish / 1 neutral, conflicted

Only ORKA

  • Golden Cross Active — bullish, trend, long horizon (23.43%)
  • Uptrend Structure Active — bullish, trend, long horizon
PRAXConflicted

3 bullish / 3 bearish / 2 neutral, conflicted

Only PRAX

  • Death Cross Active — bearish, trend, long horizon (8.51%)
  • ADX Trend Strengthening — neutral, trend, medium horizon
  • Beta Spike Warning — bearish, risk_regime, long horizon
  • Keltner Channel Breakout — bullish, volatility, short horizon

Both carry 4 more signals that do not separate them: ATR Expansion - Breakout Mode, EMA Ribbon Expansion Bullish, Low Volume Rally Warning, TRIX Bullish Signal.

ORKA leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

ORKAConfirmed strength

Price and the AIQ Score both moved up over the latest session (price +0.34%, AIQ +1 points).

PRAXConfirmed strength

Price and the AIQ Score both moved up over the latest session (price +1.04%, AIQ +1 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1PRAX closes the Momentum gap — currently 33 points behind, the largest single contributor to ORKA's edge.
  2. 2PRAX's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3ORKA's conflicting signal state resolves bearish — it currently carries 4 bullish and 1 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

ORKA leads on balance
MetricORKAPRAX
Revenue growth (YoY)0%0%
EPS growth (YoY)4.5%-12.5%
Gross margin0%0%
Operating margin0%0%
Return on equity (TTM)-4.2%-7.5%
Debt to equity00

Performance

ORKA leads 5 of 6 windows
MetricORKAPRAX
1 week (5 sessions)2.4%18.2%
1 month (20 sessions)46.5%35.7%
3 months (63 sessions)-6.5%-12.8%
6 months (126 sessions)70.1%-4.2%
Year to date247.6%11.3%
1 year (252 sessions)272.3%78.7%

Technicals

ORKA has the stronger structure
MetricORKAPRAX
RSI (14)64.461.4
ADX (14)35.223.4
Price vs 50-day17.5%13.2%
Price vs 200-day45%4.3%
Volatility (1M, annualized)64.3%93.7%

Risk

ORKA is the more resilient
MetricORKAPRAX
Beta1.41.58
Sharpe ratio2.291.13
Sortino ratio4.31.93
Max drawdown-36.4%-38.1%
Current drawdown-6.8%-15.1%
Annualized volatility69.1%75.1%
Value at risk (95%)-5.3%-5.5%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, ORKA or PRAX?

On the Algovestiq AIQ Score, ORKA is the stronger of the two as of Nov 15, 2026, scoring 77 against PRAX's 57. The edge comes from momentum and quality. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is ORKA or PRAX the better buy right now?

ORKA carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Stable — 4 of 5 covered evidence groups agree. A Stable rating means the gap is wide and the evidence is broad, so the conclusion is unlikely to turn on a single session.

Why does the AIQ Score favor ORKA over PRAX?

The composite weights Quality, Value, Momentum and Risk Resilience. ORKA leads Momentum by 33 points; ORKA leads Quality by 11 points; ORKA leads Risk Resilience by 6 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, ORKA or PRAX?

Analyst price targets imply +9.2% upside for ORKA and +101.2% for PRAX, so the Street currently favors PRAX. That points the opposite way to the AIQ Score, which favors ORKA. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, ORKA or PRAX?

Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, ORKA or PRAX?

ORKA on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, ORKA or PRAX?

ORKA on the Momentum factor, by 33 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, ORKA or PRAX?

ORKA is the more resilient of the two, so the other name carries the higher downside risk. ORKA on Risk Resilience, by 6 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is ORKA more profitable than PRAX?

ORKA leads on the comparable margin measures — gross margin 0% vs 0%; operating margin 0% vs 0%; ttm roe -4.2% vs -7.5%.

Is ORKA's lead over PRAX getting stronger or weaker?

ORKA lead: Strengthening — the AIQ differential moved from 11 to 20 points over 30 sessions. This is measured from 45 daily comparison snapshots between 2026-09-14 and 2026-11-13. The lead has not changed hands in that window.

What would change the ORKA vs PRAX verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: PRAX closes the Momentum gap — currently 33 points behind, the largest single contributor to ORKA's edge; PRAX's Death Cross Active resolves — a bearish trend rule currently active against it; ORKA's conflicting signal state resolves bearish — it currently carries 4 bullish and 1 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about ORKA and PRAX?

ORKA: 4 bullish / 1 bearish / 1 neutral, conflicted. PRAX: 3 bullish / 3 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on ORKA is Golden Cross Active (bullish, long horizon). On PRAX it is Death Cross Active (bearish, long horizon).

Compare ORKA and PRAX with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.